Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald B Brock

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
BJU International|January 20, 2011
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension studyCraig F Donatucci, Gerald B Brock, Evan R Goldfischer, et al.
The Journal of Urology|October 8, 2013
Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studiesGerald B Brock, Kevin T McVary, Claus G Roehrborn, et al.
The Journal of Sexual Medicine|April 7, 2010
Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculationStanley E Althof, Gerald B Brock, Raymond C Rosen, et al.
Urology|September 19, 2006
Through the eyes of women: the partners' perspective on tadalafilStanley E Althof, J Francois Eid, David R Talley, et al.
Journal of Endourology|January 22, 2005
Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsyDarren T Beiko, James D Watterson, Bodo E Knudsen, et al.
The Journal of Urology|June 18, 2004
Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomyAndrew J Stephenson, Michael P Chetner, Keith Rourke, et al.
The Journal of Urology|August 18, 2004
Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trialFrancesco Montorsi, Harin Padma Nathan, Andrew McCullough, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 6, 2020
Clinical pearls to managing men's health conditions during the COVID-19 pandemicLuke Witherspoon, Ryan Fitzpatrick, Premal Patel, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 12, 2018
Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatmentDean S Elterman, Anika R Petrella, Lauren M Walker, et al.
The Journal of Urology|May 10, 2022
The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA/SMSNA GuidelineTrinity J Bivalacqua, Bryant K Allen, Gerald B Brock, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
BJU International|January 20, 2011
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension studyCraig F Donatucci, Gerald B Brock, Evan R Goldfischer, et al.
The Journal of Urology|October 8, 2013
Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studiesGerald B Brock, Kevin T McVary, Claus G Roehrborn, et al.
The Journal of Sexual Medicine|April 7, 2010
Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculationStanley E Althof, Gerald B Brock, Raymond C Rosen, et al.
Urology|September 19, 2006
Through the eyes of women: the partners' perspective on tadalafilStanley E Althof, J Francois Eid, David R Talley, et al.
Journal of Endourology|January 22, 2005
Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsyDarren T Beiko, James D Watterson, Bodo E Knudsen, et al.
The Journal of Urology|June 18, 2004
Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomyAndrew J Stephenson, Michael P Chetner, Keith Rourke, et al.
The Journal of Urology|August 18, 2004
Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trialFrancesco Montorsi, Harin Padma Nathan, Andrew McCullough, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 6, 2020
Clinical pearls to managing men's health conditions during the COVID-19 pandemicLuke Witherspoon, Ryan Fitzpatrick, Premal Patel, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 12, 2018
Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatmentDean S Elterman, Anika R Petrella, Lauren M Walker, et al.
The Journal of Urology|May 10, 2022
The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA/SMSNA GuidelineTrinity J Bivalacqua, Bryant K Allen, Gerald B Brock, et al.
Pageof 9